Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.
ENTA
$10.99
-1.88%
ENTA
· Enanta Pharmaceuticals Inc
$10.99
-0.21 (-1.88%)
At close · Nov 13
Return incl. dividend (before tax)
Q2 2024 earnings call transcript
Market Cap
$320.09M
Shares
29.13M
Volume · Nov 13
127.7K
Avg daily vol (3M)
261.95K
All webcasts
Earnings call · FY2024 Q4
Enanta Pharmaceuticals Inc (ENTA) Q4 2024 Earnings Call
Revenue · derived Q4
$14.61M
-22.8% YoY
Net income · derived Q4
-$28.82M
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Nov 25, 2024 · complete as-filed document
SEC periodic report
10-K report
Filed Nov 27, 2024 · complete as-filed document